Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for +publisher:"University of Toronto" +contributor:("Gariepy, Jean"). Showing records 1 – 4 of 4 total matches.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters


University of Toronto

1. Wei. Identification of Cellular Components Interacting with the Shiga-like Toxin 1 A1 Chain (SLT-1 A1).

Degree: 2012, University of Toronto

Shiga-like toxin 1 (SLT-1) is produced by Escherichia coli strains like the pathogenic strain O157:H7. These bacterial strains are responsible for worldwide cases of food… (more)

Subjects/Keywords: protein toxin; shiga-like toxin 1; 0307

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wei. (2012). Identification of Cellular Components Interacting with the Shiga-like Toxin 1 A1 Chain (SLT-1 A1). (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/32501

Note: this citation may be lacking information needed for this citation format:
Author name may be incomplete

Chicago Manual of Style (16th Edition):

Wei. “Identification of Cellular Components Interacting with the Shiga-like Toxin 1 A1 Chain (SLT-1 A1).” 2012. Masters Thesis, University of Toronto. Accessed August 25, 2019. http://hdl.handle.net/1807/32501.

Note: this citation may be lacking information needed for this citation format:
Author name may be incomplete

MLA Handbook (7th Edition):

Wei. “Identification of Cellular Components Interacting with the Shiga-like Toxin 1 A1 Chain (SLT-1 A1).” 2012. Web. 25 Aug 2019.

Note: this citation may be lacking information needed for this citation format:
Author name may be incomplete

Vancouver:

Wei. Identification of Cellular Components Interacting with the Shiga-like Toxin 1 A1 Chain (SLT-1 A1). [Internet] [Masters thesis]. University of Toronto; 2012. [cited 2019 Aug 25]. Available from: http://hdl.handle.net/1807/32501.

Note: this citation may be lacking information needed for this citation format:
Author name may be incomplete

Council of Science Editors:

Wei. Identification of Cellular Components Interacting with the Shiga-like Toxin 1 A1 Chain (SLT-1 A1). [Masters Thesis]. University of Toronto; 2012. Available from: http://hdl.handle.net/1807/32501

Note: this citation may be lacking information needed for this citation format:
Author name may be incomplete


University of Toronto

2. Fischer, Nicholas William. The Functional and Clinical Consequences of TP53 Mutations in Cancer.

Degree: PhD, 2019, University of Toronto

 The discovery of genetic variants linked to cancer have provided useful biomarkers for diagnostics, prognostics, and therapeutic targets. Mutations in the TP53 gene that encodes… (more)

Subjects/Keywords: Bioinformatics; Cancer; Protein Oligomerization; TP53; Transcription Factor; Tumor Suppressor; 0306

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fischer, N. W. (2019). The Functional and Clinical Consequences of TP53 Mutations in Cancer. (Doctoral Dissertation). University of Toronto. Retrieved from http://hdl.handle.net/1807/95840

Chicago Manual of Style (16th Edition):

Fischer, Nicholas William. “The Functional and Clinical Consequences of TP53 Mutations in Cancer.” 2019. Doctoral Dissertation, University of Toronto. Accessed August 25, 2019. http://hdl.handle.net/1807/95840.

MLA Handbook (7th Edition):

Fischer, Nicholas William. “The Functional and Clinical Consequences of TP53 Mutations in Cancer.” 2019. Web. 25 Aug 2019.

Vancouver:

Fischer NW. The Functional and Clinical Consequences of TP53 Mutations in Cancer. [Internet] [Doctoral dissertation]. University of Toronto; 2019. [cited 2019 Aug 25]. Available from: http://hdl.handle.net/1807/95840.

Council of Science Editors:

Fischer NW. The Functional and Clinical Consequences of TP53 Mutations in Cancer. [Doctoral Dissertation]. University of Toronto; 2019. Available from: http://hdl.handle.net/1807/95840


University of Toronto

3. Latimer, Caitlin. Octaarginine Labelled 30 nm Gold Nanoparticles as Agents for Enhanced Radiotherapy.

Degree: 2013, University of Toronto

Traditional radiation therapy is limited by the radiotoxic effects on surrounding healthy tissues. This project investigated the use of a gold nanoparticle (AuNP) conjugated to… (more)

Subjects/Keywords: gold nanoparticle; radiotherapy; 0760

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Latimer, C. (2013). Octaarginine Labelled 30 nm Gold Nanoparticles as Agents for Enhanced Radiotherapy. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/43000

Chicago Manual of Style (16th Edition):

Latimer, Caitlin. “Octaarginine Labelled 30 nm Gold Nanoparticles as Agents for Enhanced Radiotherapy.” 2013. Masters Thesis, University of Toronto. Accessed August 25, 2019. http://hdl.handle.net/1807/43000.

MLA Handbook (7th Edition):

Latimer, Caitlin. “Octaarginine Labelled 30 nm Gold Nanoparticles as Agents for Enhanced Radiotherapy.” 2013. Web. 25 Aug 2019.

Vancouver:

Latimer C. Octaarginine Labelled 30 nm Gold Nanoparticles as Agents for Enhanced Radiotherapy. [Internet] [Masters thesis]. University of Toronto; 2013. [cited 2019 Aug 25]. Available from: http://hdl.handle.net/1807/43000.

Council of Science Editors:

Latimer C. Octaarginine Labelled 30 nm Gold Nanoparticles as Agents for Enhanced Radiotherapy. [Masters Thesis]. University of Toronto; 2013. Available from: http://hdl.handle.net/1807/43000


University of Toronto

4. Broad, Amaalia. A Role for ETA(253-412) in Peptide-based Delivery of Therapeutic Molecules into Cells.

Degree: 2009, University of Toronto

The delivery of biomolecules by cell penetrating peptides (CPPs) is an innovative therapeutic strategy. However delivery efficiency is hindered by the entrapment of CPPs in… (more)

Subjects/Keywords: Drug Delivery; Endosomal Escape; 0491

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Broad, A. (2009). A Role for ETA(253-412) in Peptide-based Delivery of Therapeutic Molecules into Cells. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/18890

Chicago Manual of Style (16th Edition):

Broad, Amaalia. “A Role for ETA(253-412) in Peptide-based Delivery of Therapeutic Molecules into Cells.” 2009. Masters Thesis, University of Toronto. Accessed August 25, 2019. http://hdl.handle.net/1807/18890.

MLA Handbook (7th Edition):

Broad, Amaalia. “A Role for ETA(253-412) in Peptide-based Delivery of Therapeutic Molecules into Cells.” 2009. Web. 25 Aug 2019.

Vancouver:

Broad A. A Role for ETA(253-412) in Peptide-based Delivery of Therapeutic Molecules into Cells. [Internet] [Masters thesis]. University of Toronto; 2009. [cited 2019 Aug 25]. Available from: http://hdl.handle.net/1807/18890.

Council of Science Editors:

Broad A. A Role for ETA(253-412) in Peptide-based Delivery of Therapeutic Molecules into Cells. [Masters Thesis]. University of Toronto; 2009. Available from: http://hdl.handle.net/1807/18890

.